Additionally, the location of these skin issues can provide further clues
Two large trials from drugmaker Novo Nordisk found that an oral version of semaglutide, the active ingredient in Ozempic and Wegovy, failed to delay Alzheimers disease progression in more than 3,800 adults with mild cognitive impairment or early dementia
Specific subtypes assessed included Alzheimers disease, vascular dementia, frontotemporal dementia, Parkinsons disease, extrapyramidal and movement disorders, and dementia with Lewy bodies
Work with a Professional : At Refine Laser & Skin Care, our team offers personalized coaching and support to keep you on track
FDA approval as a treatment for obesity or overweight in adults
Side Effects and Safety Considerations The most common side effects in trials were gastrointestinal including nausea, vomiting, and diarrhoea and were dose-dependent